The relationship between sleep apnea and Alzheimer's disease in a unique mouse model: role for microglia
独特小鼠模型中睡眠呼吸暂停与阿尔茨海默病之间的关系:小胶质细胞的作用
基本信息
- 批准号:10288404
- 负责人:
- 金额:$ 38.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAmyloid beta-ProteinAnimal ModelApneaAutophagocytosisBiochemicalBirthBrainCellsCessation of lifeCharacteristicsCognitiveCognitive deficitsComplexDementiaDepositionDevelopmentDiseaseDisease ProgressionEconomicsEnvironmentExhibitsExposure toFamilyFoundationsFutureGene ExpressionGeneticHippocampus (Brain)HistologicHypoxiaImmuneImmune responseImmunohistochemistryImpaired cognitionIndividualInflammatoryInflammatory ResponseLaboratoriesLifeMaternal ExposureMeasuresMetabolicMicrogliaModelingMolecularMorphologyMusNerve DegenerationNeurodegenerative DisordersNeuronsNeurophysiology - biologic functionOnset of illnessParentsPartner in relationshipPathologyPatientsPeptidesPhagocytesPopulationPregnancyProcessQuality of lifeRattusResearch DesignRiskSenile PlaquesSeveritiesSleepSleep Apnea SyndromesSleep FragmentationsStimulusSymptomsTestingTimebrain tissueclinically relevantcomorbiditydisease phenotypeearly onsetexhaustexhaustionimmune activationin uteromacrophagemalemouse modelneuroinflammationneurotoxicnew therapeutic targetnormoxiaoffspringparent grantpatient populationpregnantprenatalrecruitrole modelsingle-cell RNA sequencingsynergism
项目摘要
There is a complex, but poorly understood relationship between Alzheimer’s disease (AD) and sleep apnea (SA).
Indeed, about half of individuals with Alzheimer’s disease (AD) also have sleep apnea (SA). Importantly, when
both pathologies are co-morbid, cognitive decline is exacerbated, which takes a severe economic toll and has
significant impact on patient and family quality of life. Indeed, SA is prevalent in almost all neurodegenerative
disorders suggesting that common underlying causal mechanisms are likely involved, given the striking overlap
in patient populations, and the similarities in symptom timing and onset. We propose that the synergy between
AD and SA results from initial over engagement of microglia, CNS resident macrophages that are involved in the
development of both pathologies. In early AD pathology, microglia are recruited to and accumulate around beta
amyloid (Aβ) plaques, initially walling off and protecting the surrounding healthy brain tissue from toxic Aβ
peptides. However, over the course of AD progression, sustained Aβ exposure induces microglial inflammatory
activities, compounding ongoing neuronal damage. Coincidentally, intermittent hypoxia and sleep fragmentation,
both of which are hallmarks of SA, can prime microglial inflammatory and phagocytic activities, also causing
neuroinflammation, microglial activation, and neuronal degeneration. Accordingly, we posit that in the context of
combined SA and AD, the normally protective capacity of microglia to wall the brain off from neurotoxic Aβ, and
phagocytose cell debris, becomes overwhelmed, effectively “exhausting” them metabolically, allowing ongoing
neurodegenerative processes to proceed unchecked. In the parent proposal, we modeled the intermittent
hypoxia aspect of SA in rat dams during gestation (GIH) and found that her adult male offspring spontaneously
developed sleep apnea as adults, which was reflected as an increase in apneas during sleep. Further, microglia
from male GIH offspring had primed inflammatory responses to immune challenges, setting the stage for their
exaggerated immune response with coincident AD pathology. In this supplement, we will test the hypothesis that
adult 5XFAD mice exposed to gestational intermittent hypoxia (GIH) in utero exhibit increased spontaneous
apneas during presumptive sleep, increased microglial exhaustion, and enhanced neurodegeneration with age.
We will evaluate apneas and cognitive dysfunction over time in adult, WT and 5XFAD littermate offspring, as
measures of symptom onset and severity. We will also assess molecular, biochemical and histologic aspects of
microglial function in these offspring. If microglial contributions to these disorders can be understood, they may
represent a novel therapeutic target that can be manipulated to reduce reciprocal, synergistic, disease
interactions between SA and AD. These studies will form the foundation for future R01 studies designed to probe
the mechanistic contributions of exhausted microglia to worsened SA and AD phenotypes when present
together.
阿尔茨海默氏病(AD)和睡眠呼吸暂停(SA)之间存在复杂但了解的关系。
确实,大约一半的阿尔茨海默氏病(AD)患有睡眠呼吸暂停(SA)。重要的是,什么时候
两种病理都是合并的,认知能力下降均加剧,这造成了严重的经济损失,并且已有
对患者和家庭生活质量的重大影响。实际上,SA在几乎所有神经退行性中都普遍存在
鉴于引人注目的重叠,可能涉及常见的基本因果机制的疾病可能涉及
在患者人群中,以及症状时间和发作的相似之处。我们建议
AD和SA是由于小胶质细胞的最初参与而导致的,CNS居民巨噬细胞涉及
两种病理的发展。在早期AD病理学中,小胶质细胞被招募到β周围并积聚
淀粉样蛋白(Aβ)斑块,最初隔离并保护周围健康的脑组织免受毒性Aβ的影响
肽。但是,在AD进展过程中,持续的Aβ暴露会诱导小胶质细胞炎症
活动,复合正在进行的神经元损害。巧合的是,间歇性缺氧和睡眠碎片化,
两者都是SA的标志,可以给小胶质细胞炎症和吞噬活性产生刺激性,也导致
神经炎症,小胶质细胞激活和神经元变性。根据,我们认为在
SA和AD合并,通常受保护的小胶质细胞能够使大脑从神经毒性Aβ中闭合大脑,并且
吞噬细胞碎片碎片,不知所措,有效地“筋疲力尽”,允许持续
神经退行性过程未经检查。在父母的建议中,我们建立了间歇性的建模
妊娠期间大鼠大坝中SA的缺氧方面(GIH),发现她的成年男性后代赞助
成年后发展为睡眠呼吸暂停,这反映为睡眠期间呼吸暂停。此外,小胶质细胞
从男性GIH后代开始对免疫挑战的炎症反应,为他们的舞台奠定了基础
与一致的AD病理学夸张的免疫响应。在这种补充中,我们将检验以下假设
在子宫内暴露于妊娠间歇性缺氧(GIH)的成年5XFAD小鼠提高了赞助商
在推定睡眠期间的呼吸暂停,小胶质疲劳增加以及随着年龄的增长而增强的神经退行性。
我们将在成人,WT和5XFAD同窝后代中评估呼吸暂停和认知功能障碍,为
症状发作和严重程度的度量。我们还将评估分子,生化和组织学方面
这些后代中的小胶质功能。如果可以理解对这些疾病的小胶质贡献,则可能
代表一个可以操纵的新型热目标,以减少互惠,协同,疾病
SA和AD之间的相互作用。这些研究将为未来的R01研究奠定基础,旨在证明
耗尽的小胶质细胞对存在的机械贡献对SA和AD表型的恶化,
一起。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tracy L Baker其他文献
Tracy L Baker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tracy L Baker', 18)}}的其他基金
Is gestational sleep apnea a previously unrecognized cause of maternal immune activation that predisposes male offspring to disease-relevant neural dysfunction?
妊娠期睡眠呼吸暂停是否是一种以前未被认识到的母体免疫激活的原因,导致男性后代容易出现与疾病相关的神经功能障碍?
- 批准号:
10680972 - 财政年份:2023
- 资助金额:
$ 38.19万 - 项目类别:
Fetal reprogramming by gestational intermittent hypoxia impairs respiratory neuromotor control in adult offspring
妊娠间歇性缺氧引起的胎儿重编程损害成年后代的呼吸神经运动控制
- 批准号:
10093126 - 财政年份:2019
- 资助金额:
$ 38.19万 - 项目类别:
Mechanisms of inactivity-induced respiratory plasticity
不活动引起的呼吸可塑性机制
- 批准号:
8023774 - 财政年份:2011
- 资助金额:
$ 38.19万 - 项目类别:
Mechanisms of inactivity-induced respiratory plasticity
不活动引起的呼吸可塑性机制
- 批准号:
8386955 - 财政年份:2011
- 资助金额:
$ 38.19万 - 项目类别:
Mechanisms of inactivity-induced respiratory plasticity
不活动引起的呼吸可塑性机制
- 批准号:
8209201 - 财政年份:2011
- 资助金额:
$ 38.19万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 38.19万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 38.19万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 38.19万 - 项目类别: